Market revenue in 2023 | USD 81.5 million |
Market revenue in 2030 | USD 135.6 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Functional genomics |
Fastest growing segment | Pathway Analysis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery |
Key market players worldwide | Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Eppendorf, Eurofins Scientific SE, Roche Holding AG ADR, GE Aerospace, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc, Qiagen NV, Quest Diagnostics Inc, Thermo Fisher Scientific Inc, 23andMe Holding Co Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genomics market will help companies and investors design strategic landscapes.
Functional genomics was the largest segment with a revenue share of 32.64% in 2023. Horizon Databook has segmented the South Africa genomics market based on functional genomics, epigenomics, pathway analysis, biomarker discovery covering the revenue growth of each sub-segment from 2018 to 2030.
One out of every four people in South Africa is affected by cancer. Rise in the prevalence of cancer in South Africa has led to an increased need for advanced genomics techniques for detection of cancer. This increased need for rapid diagnosis has led to the growth of genomics market. According to The Lancet, South Africa will witness about a 78% increase in cancer cases by 2030.
In addition, there will be more investments in innovations that aim to address healthcare problems in the country. However, the struggle is expected to persist for harmonization of regulatory activities in the country. South Africa ranked 50th on the World Cancer Research Fund's list of countries with the highest cases of cancer.
In addition, there are organizations, such as the Wellcome Trust Africa, which initiated the Centre Genomics Program and is working toward the development of better NGS analysis and data storage for biomedical health research conducted in the region.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa genomics market , including forecasts for subscribers. This country databook contains high-level insights into South Africa genomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account